Bortezomib 3.5mg Injection: Product Information and Handling Notes
Bortezomib 3.5mg Injection is a prescription antineoplastic medicine used in specialist cancer care, most commonly in treatment protocols for multiple myeloma and mantle cell lymphoma. It belongs to a class of medicines known as proteasome inhibitors and should only be prepared, handled, and administered by trained healthcare professionals in an appropriate clinical setting. MedlinePlus states […]